Bonus Presentations
Non-CME/CE Bonus Presentation
CRYSVITA® (burosumab-twza): Targeted Treatment for Adults with X-Linked Hypophosphatemia (XLH)
Speaker: Samy Metyas, MD
Sponsored by Kyowa Kirin
Non-CME/CE Bonus Presentation
The History, the Present, the Future: Kevzara (sarilumab) Is Now Approved in pJIA, in Addition to PMR and RA
Speaker: Amro Balki, MD, FACR, Rheumatology
Sponsored by Sanofi
Non-CME/CE Bonus Presentation
Across the Ages: Exploring a Therapy for: Patients 2+ with pJIA; Adults with RA; and Adults with GCA (Mean Age 71)
Speaker: Sergio Schwartzman, MD
Sponsored by AbbVie
Non-CME/CE Bonus Presentation
Can CAR T Cell Therapy Reframe the Treatment of Select Rheumatic Diseases?
Speaker: Maximilian Konig, MD
Sponsored by Bristol Myers Squibb
Non-CME/CE Bonus Presentation
Evidence-Based Treatment of Recurrent Pericarditis
Speaker: Steven Call, MD
Sponsored by Kiniksa Pharmaceuticals
Non-CME/CE Bonus Presentation
Reframing Sjögren’s Disease: A Systemic Disease That Can Be Serious and Progressive
Sponsored by Novartis
Non-CME/CE Bonus Presentation
What Does Zero Disease Activity Mean to You? A Different Way of Evaluating Disease Control
Speaker: Hillary Norton, MD
Sponsored by UCB
